Phrasing is "anything but objective," former Journal of the American Medical Association deputy editor says. Harvard-led ...

Most COVID-19 vaccine hesitancy is rooted in concerns that can be addressed and effectively reduced over time, according to a ...

WASHINGTON — Officials at the Centers for Disease Control and Prevention (CDC) discussed how to downplay concerns about COVID-19 vaccine efficacy and avoid “too precise” comparisons between the ...

Findings reveal a general decline in vaccine hesitancy during the 15 months following the COVID-19 vaccine roll-out in 2021-2022, with almost two-thirds of those initially hesitant going on to receive ...

Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or COVID vaccine injuryParticipants to include people ...

Walensky is a professor at Harvard Medical School and served as the 19th director of the Centers for Disease Control and Prevention. Once clinical trials showed that Covid-19 vaccines were safe and ...

In the early days of the coronavirus vaccine rollout, scientists were hopeful it might herald the long-awaited turning point of the pandemic, not only bringing the threat of severe disease, ...

Restoring faith in public health is clearly not one of Kennedy’s goals, nor is it within his skillset.

Pfizer said today its COVID-19 vaccine has saved more than 14 million lives worldwide, after President Donald Trump urged pharmaceutical companies to justify the success of their pandemic drugs. In a ...

WASHINGTON — As COVID-19 vaccinations continue and accelerate across the U.S., a new rapid expert consultation from the National Academies of Sciences, Engineering, and Medicine offers advice for ...

Immunizations used to treat COVID-19, respiratory syncytial virus (RSV) and influenza safely reduce the risk of adverse outcomes among people of all ages, according to a systematic analysis of 511 ...